相似文献
1
The "post-COVID" syndrome: How deep is the damage?“新冠后”综合征：损害有多严重？
J Med Virol. 2021 Feb;93(2):673-674. doi: 10.1002/jmv.26465. Epub 2020 Sep 29.
2
Listening to COVID-19 survivors: what they need after early discharge from hospital - a qualitative study.倾听 COVID-19 幸存者的声音：他们在早期出院后需要什么——一项定性研究。
Int J Qual Stud Health Well-being. 2022 Dec;17(1):2030001. doi: 10.1080/17482631.2022.2030001.
3
Inflammatory Profiles and Clinical Features of Coronavirus 2019 Survivors 3 Months After Discharge in Wuhan, China.中国武汉新冠肺炎出院患者 3 个月时的炎症特征和临床特征。
J Infect Dis. 2021 Nov 16;224(9):1473-1488. doi: 10.1093/infdis/jiab181.
4
Characterizing non-critically ill COVID-19 survivors with and without in-hospital rehabilitation.描述伴有和不伴有院内康复的非危重症 COVID-19 幸存者的特征。
Sci Rep. 2021 Oct 26;11(1):21039. doi: 10.1038/s41598-021-00246-1.
5
Impact of severe SARS-CoV-2 infection on nutritional status and subjective functional loss in a prospective cohort of COVID-19 survivors.严重严重急性呼吸综合征冠状病毒 2 型感染对 COVID-19 幸存者前瞻性队列中营养状况和主观功能丧失的影响。
BMJ Open. 2021 Jul 14;11(7):e048948. doi: 10.1136/bmjopen-2021-048948.
6
Pulmonary rehabilitation in post-discharge treatment of patients with COVID-19 pneumonia.新型冠状病毒肺炎患者出院后治疗中的肺康复
Asian J Surg. 2022 Oct;45(10):2021. doi: 10.1016/j.asjsur.2022.04.066. Epub 2022 May 2.
7
Post-COVID-19 functional status six-months after hospitalization.新冠病毒感染康复后六个月的功能状态（住院后）
J Infect. 2021 Apr;82(4):e31-e33. doi: 10.1016/j.jinf.2020.12.022. Epub 2020 Dec 26.
8
A Nomogram Based on Myocardial Damage and Novel Inflammatory Indexes for Post-Discharge Survival Rates of COVID-19.基于心肌损伤和新型炎症指标的 COVID-19 患者出院后生存率预测列线图。
Clin Lab. 2022 Mar 1;68(3). doi: 10.7754/Clin.Lab.2021.210745.
9
High in-hospital and post-discharge mortality in patients with a pre-existing diagnosis of heart failure hospitalized due to COVID-19.因新冠病毒疾病（COVID-19）住院的、先前已诊断患有心力衰竭的患者，院内及出院后死亡率较高。
Kardiol Pol. 2022;80(1):90-92. doi: 10.33963/KP.a2021.0163. Epub 2021 Nov 30.
10
Post discharge positive re-tests in COVID-19: common but clinically non-significant.新型冠状病毒肺炎出院后复查呈阳性：常见但临床意义不大。
Infect Dis (Lond). 2020 Oct;52(10):743-745. doi: 10.1080/23744235.2020.1780309. Epub 2020 Jun 24.
引用本文的文献
1
[SARS-CoV-2 and post-COVID-19 syndrome in paediatric rheumatology: A scoping review].[儿童风湿病中的新型冠状病毒2型及新冠后综合征：一项范围综述]
Rev Colomb Reumatol. 2022 Nov 16. doi: 10.1016/j.rcreu.2022.10.003.
2
[Guillain Barré syndrome in the paediatric population. Consequence of active infection or long Covid?].[小儿群体中的吉兰-巴雷综合征。是活动性感染还是长期新冠的后果？]
Rev Colomb Reumatol. 2022 Oct-Dec;29(4):335-346. doi: 10.1016/j.rcreu.2022.05.003. Epub 2022 Aug 10.
3
[Fibromyalgia in the new era of SARS-CoV-2 infection and post-COVID-19 syndrome: A scoping review].[新型冠状病毒感染和新冠后综合征新时代的纤维肌痛：一项范围综述]
Rev Colomb Reumatol. 2022 Jun;29:S7-S16. doi: 10.1016/j.rcreu.2022.03.008. Epub 2022 May 3.
4
Mood disorders after COVID-19 infection: a single-center experience.新冠病毒感染后的情绪障碍：单中心经验
Malawi Med J. 2025 Jan 13;36(4):238-243. doi: 10.4314/mmj.v36i4.1. eCollection 2025 Jan.
5
Persistent ENT Manifestations in Individuals who Recovered from COVID-19: A Systematic Review.新冠康复者的持续性耳鼻喉表现：一项系统综述
Int Arch Otorhinolaryngol. 2024 Mar 15;28(4):e697-e701. doi: 10.1055/s-0043-1777805. eCollection 2024 Oct.
6
Cardiovascular Disease in Post-Acute COVID-19 Syndrome: A Comprehensive Review of Pathophysiology and Diagnosis Approach.急性 COVID-19 综合征后心血管疾病：病理生理学与诊断方法的综合综述
Rev Cardiovasc Med. 2023 Jan 13;24(1):28. doi: 10.31083/j.rcm2401028. eCollection 2023 Jan.
7
Long COVID Definition, Symptoms, Risk Factors, Epidemiology and Autoimmunity: A Narrative Review.长新冠的定义、症状、风险因素、流行病学及自身免疫：一篇叙述性综述
Am J Med Open. 2024 Feb 14;11:100068. doi: 10.1016/j.ajmo.2024.100068. eCollection 2024 Jun.
8
Long-COVID Prevalence and Its Association with Health Outcomes in the Post-Vaccine and Antiviral-Availability Era.疫苗接种和抗病毒药物可及时代的长期新冠患病率及其与健康结局的关联
J Clin Med. 2024 Feb 21;13(5):1208. doi: 10.3390/jcm13051208.
9
Assessment of Some Risk Factors and Biological Predictors in the Post COVID-19 Syndrome in Asthmatic Patients.哮喘患者新冠后综合征中一些风险因素和生物学预测指标的评估
J Pers Med. 2023 Dec 22;14(1):21. doi: 10.3390/jpm14010021.
10
Angiotensin-Converting Enzyme-2 () with Interferon-Induced Transmembrane Protein-3 () Genetic Variants and Interleukin-6 as Severity and Risk Predictors among COVID-19 Egyptian Population.血管紧张素转换酶2（）与干扰素诱导跨膜蛋白3（）基因变异以及白细胞介素-6作为埃及新冠肺炎患者严重程度和风险预测指标的研究
Int J Microbiol. 2023 Dec 21;2023:6384208. doi: 10.1155/2023/6384208. eCollection 2023.
本文引用的文献
1
Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020.症状持续时间和多州医疗保健系统网络中 COVID-19 门诊患者恢复健康延迟的风险因素 - 美国，2020 年 3 月至 6 月。
MMWR Morb Mortal Wkly Rep. 2020 Jul 31;69(30):993-998. doi: 10.15585/mmwr.mm6930e1.
2
Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation.COVID-19 感染幸存者出院后的症状和康复需求：一项横断面评估。
J Med Virol. 2021 Feb;93(2):1013-1022. doi: 10.1002/jmv.26368. Epub 2020 Aug 17.
3
Persistent Symptoms in Patients After Acute COVID-19.急性 COVID-19 后患者的持续症状。
JAMA. 2020 Aug 11;324(6):603-605. doi: 10.1001/jama.2020.12603.
4
Thyroid Function Analysis in 50 Patients with COVID-19: A Retrospective Study.50 例 COVID-19 患者甲状腺功能分析：一项回顾性研究。
Thyroid. 2021 Jan;31(1):8-11. doi: 10.1089/thy.2020.0363. Epub 2020 Jul 10.
5
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.中国2019年冠状病毒病（COVID-19）疫情的特征及重要经验教训：来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
6
Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19).新冠肺炎（COVID-19）康复过程中胸部 CT 肺部变化的时间进程。
Radiology. 2020 Jun;295(3):715-721. doi: 10.1148/radiol.2020200370. Epub 2020 Feb 13.
7
ICU-acquired weakness and recovery from critical illness.重症监护病房获得性肌无力与危重病康复
N Engl J Med. 2014 Apr 24;370(17):1626-35. doi: 10.1056/NEJMra1209390.
Zotero 插件